Dextrose Monohydrate, Sodium Chloride, Sodium Lactate, Calcium Chloride, Magnesium Chloride Solution
Fresenius Medical Care North America
Open FDA's page for this record- Discontinued date
- 09/10/2026
- Update type
- New
- Initial posting date
- 09/10/2026
- Package NDC
- 46163-212-95
- Generic name
- Dextrose Monohydrate, Sodium Chloride, Sodium Lactate, Calcium Chloride, Magnesium Chloride Solution
- Contact info
- 800-323-5188
- Related info
- A business decision was made to discontinue manufacture of the drug.
- Update date
- 09/10/2026
- Dosage form
- Solution
- Presentation
- DELFLEX, Solution, 18.4 mg/100 mL; 4.25 g/100 mL; 5.08 mg/100 mL; 538 mg/100 mL; 448 mg/100 mL (NDC 46163-212-95)
- Company name
- Fresenius Medical Care North America
- Status
- To Be Discontinued
- Therapeutic category
- Renal
- Harmonized identifiers (openFDA)
- Application number
- NDA020171
- Brand name
- DELFLEX
- Generic name
- DEXTROSE MONOHYDRATE, SODIUM CHLORIDE, SODIUM LACTATE, CALCIUM CHLORIDE, MAGNESIUM CHLORIDE
- Manufacturer name
- Fresenius Medical Care de Mexico, S.A. de C.V.
- Product NDC
- 46163-212, 46163-209, 46163-206
- Product type
- HUMAN PRESCRIPTION DRUG
- Route
- INTRAPERITONEAL
- Substance name
- DEXTROSE MONOHYDRATE, SODIUM CHLORIDE, SODIUM LACTATE, CALCIUM CHLORIDE, MAGNESIUM CHLORIDE
- SPL ID
- 579dba0f-f820-8f9a-e063-6294a90a76b0
- SPL set ID
- a98facd6-9daa-4d37-8209-63a0599dbfaa
- Package NDC
- 46163-209-92, 46163-209-94, 46163-209-95, 46163-212-95, 46163-212-92, 46163-212-94, 46163-206-92, 46163-206-94, 46163-206-95
- UNII
- LX22YL083G, 02F3473H9O, 451W47IQ8X, M4I0D6VV5M, TU7HW0W0QT